{
    "Trade/Device Name(s)": [
        "Folate on the Access Immunoassay Systems",
        "Access Folate Assay"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K060774",
    "Predicate Device Reference 510(k) Number(s)": [
        "K932887",
        "K943149",
        "K955434"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGN"
    ],
    "Summary Letter Date": "March 20, 2006",
    "Summary Letter Received Date": "March 22, 2006",
    "Submission Date": "March 20, 2006",
    "Regulation Number(s)": [
        "21CFR862.1295"
    ],
    "Regulation Name(s)": [
        "Folic acid test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Folic acid"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (heparin)",
        "Red blood cells"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Access Immunoassay Systems",
        "Access",
        "Access 2",
        "Synchron LX i725",
        "UniCel DxI 800",
        "UniCel DxC 600i"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Paramagnetic particle",
        "Two-step competitive binding receptor assay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Lysing Agent",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for Access Folate on the Access Immunoassay Systems for quantitative folic acid determination in serum, plasma (heparin), and red blood cells",
    "Indications for Use Summary": "Quantitative determination of folic acid levels in human serum, plasma (heparin), and red blood cells to assess folate status and identify recent intake or prolonged deficiency",
    "fda_folder": "Clinical Chemistry"
}